Cybin Inc. (NEO:CYBN | NYSE AMERICAN:CYBN), a biopharmaceutical company focused on progressing “Psychedelics to TherapeuticsTM”, announced that it...
MO judge keeps marijuana on ballot; MD legalization campaign launches with new ad; Senator presses SAFE Banking; FL cannabis dosage limit pushback Subscribe to...
The cannabis sector consists of 5 distinctly different categories and they each performed quite differently in August and since the end of June and YTD,...
Any analyst knows that market-reactive swings aren’t really a true indicator of what is going on inside a company. The post Psychedelics Stock Swings...
The article News You Might Have Missed: Sep 6th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
legitimate, medical psychedelics is gaining ground as an acceptable mental health therapy in clinical trials. The post How Close Is The US To A Legal Psychedelics...
Cybin Inc. (NEO:CYBN) (NYSE AMERICAN:CYBN), a biotechnology company focused on progressing Psychedelics to Therapeutics™, is pleased to announce that...